Similar articles for PMID: 32103644

Year	Number of Results
2005	1
2007	1
2009	3
2010	1
2011	3
2012	3
2013	3
2014	4
2015	5
2016	11
2017	14
2018	10
2019	10
2020	7
2021	9
2022	5
2023	1
2024	0

1

The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Lee J, Song JU. Lee J, et al. J Korean Med Sci. 2020 Mar 2;35(8):e48. doi: 10.3346/jkms.2020.35.e48. J Korean Med Sci. 2020. PMID: 32103644 Free PMC article.

2

Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Wu Q, Zhou Y, Feng FC, Zhou XM. Wu Q, et al. Chin J Integr Med. 2019 Oct;25(10):778-784. doi: 10.1007/s11655-017-2429-5. Epub 2018 Jan 15. Chin J Integr Med. 2019. PMID: 29335860

3

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?

Nathan SD, King CS. Nathan SD, et al. Drug Des Devel Ther. 2014 Jul 2;8:875-85. doi: 10.2147/DDDT.S64907. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25061279 Free PMC article. Review.

4

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.

Behr J, Nathan SD, Harari S, Wuyts W, Kirchgaessler KU, Bengus M, Gilberg F, Wells AU. Behr J, et al. Respir Med. 2018 May;138:13-20. doi: 10.1016/j.rmed.2018.03.019. Epub 2018 Mar 16. Respir Med. 2018. PMID: 29724385 Free article.

5

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.

Nathan SD, Albera C, Bradford WZ, Costabel U, Glaspole I, Glassberg MK, Kardatzke DR, Daigl M, Kirchgaessler KU, Lancaster LH, Lederer DJ, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Nathan SD, et al. Lancet Respir Med. 2017 Jan;5(1):33-41. doi: 10.1016/S2213-2600(16)30326-5. Epub 2016 Nov 19. Lancet Respir Med. 2017. PMID: 27876247

6

The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Chen CY, Chen CH, Wang CY, Lai CC, Chao CM, Wei YF. Chen CY, et al. Respir Res. 2021 Sep 15;22(1):243. doi: 10.1186/s12931-021-01839-0. Respir Res. 2021. PMID: 34526011 Free PMC article.

7

Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Cheng L, Tan B, Yin Y, Wang S, Jia L, Warner G, Jia G, Jiang W. Cheng L, et al. Clin Rehabil. 2018 Oct;32(10):1299-1307. doi: 10.1177/0269215518779122. Epub 2018 May 30. Clin Rehabil. 2018. PMID: 29843523

8

Treatment of Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Fidler L, Sitzer N, Shapera S, Shah PS. Fidler L, et al. Chest. 2018 Jun;153(6):1405-1415. doi: 10.1016/j.chest.2018.03.008. Epub 2018 Mar 17. Chest. 2018. PMID: 29559309

9

Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.

Liu HL, Chen XY, Li JR, Su SW, Ding T, Shi CX, Jiang YF, Zhu ZN. Liu HL, et al. Chest. 2016 Aug;150(2):353-66. doi: 10.1016/j.chest.2016.03.031. Epub 2016 Apr 2. Chest. 2016. PMID: 27048870

10

Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.

Corte TJ, Wort SJ, Wells AU. Corte TJ, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(1):7-19. Sarcoidosis Vasc Diffuse Lung Dis. 2009. PMID: 19960783 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year